Long and ultra-long-acting insulins, when given at sunrise, may reduce the risk of hypoglycemia during Ramadan (27, 30, 33), particularly when compared to intermediate-acting insulins (21, 23, 30). The gene discussed is INS; the disease is Hypoglycemia.